Showing 1,522 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

Dramatic Changes in Hepatitis C Treatment Expected to Continue

Editor's pick
Xconomy
7 September 2011
Access to healthcare

India: A victory for Novartis could spell death for millions

Editor's pick
The Hindu
6 September 2011
Pharmaceutical industry

'Sustainable Global Pharmacovigilance' Systems Needed To Monitor ARVs, Other Drugs

Editor's pick
Kaiser Daily Global Health Policy Report
2 September 2011
New & experimental hepatitis C treatment

Vertex Scores Big With Hepatitis Drug

Editor's pick
Investorplace.com
1 September 2011
New & experimental hepatitis C treatment

N/A

Editor's pick
HCV New Drugs Research
29 August 2011
Pharmaceutical industry

Spanish doctors told to prescribe cheaper generic drugs

Editor's pick
The Guardian
25 August 2011
Pharmaceutical industry

Gilead Aims to Duplicate HIV Success With Combo Cancer Drugs

Editor's pick
Investorplace.com
22 August 2011
Hepatitis C transmission & prevention

Teva Not Responsible for Hepatitis Outbreak, Lawyer Says

Editor's pick
Bloomberg
22 August 2011
HIV treatment for children & young people

Pediatric HIV — A Neglected Disease?

Editor's pick
New England Journal of Medicine
18 August 2011
Pharmaceutical industry

Canada: How the Conservatives killed a law providing cheap AIDS drugs to Africa

Editor's pick
This magazine
15 August 2011
Pharmaceutical industry

US approval for new three-drug combination pill

News
11 August 2011
Pharmaceutical industry

Boehringer lauded for increasing access to HIV drugs in USA

Editor's pick
Pharma Times
11 August 2011
Pharmaceutical industry

A Trade Barrier to Defeating AIDS

Editor's pick
New York Times
27 July 2011
Pharmaceutical industry

Gilead quarterly profit up 4.8% on HIV drug sales

Editor's pick
MarketWatch
26 July 2011
Pharmaceutical industry

Gilead 2nd quarter profit rises with HIV drugs

Editor's pick
Reuters
26 July 2011
Pharmaceutical industry

Implications of the Patent Pool Licenses with Gilead

Editor's pick
I-Mak
26 July 2011
Pharmaceutical industry

Drug prices to plummet in wave of expiring patents

Editor's pick
San Francisco Chronicle
25 July 2011
Pharmaceutical industry

Corporate Self-Interest And Strategic Choices: Gilead Licenses To Medicines Patent Pool

Editor's pick
Intellectual Property Watch
23 July 2011
Pharmaceutical industry

ViiV denies changing discounts to AIDS drugs

Editor's pick
Pharma Times
22 July 2011
Access to healthcare

Bad news for drug prices in middle-income countries

Editor's pick
IRIN Plus News
20 July 2011
Access to healthcare

South African government mulls state pharmaceutical company

Editor's pick
Mail & Guardian
19 July 2011
Pharmaceutical industry

Boehringer Ingelheim and Bristol-Myers Squibb negotiate with Medicines Patent Pool

Editor's pick
UNITAID
19 July 2011
Pharmaceutical industry

Anti-HIV drug made by GM plants begins trials in humans

Editor's pick
The Guardian
19 July 2011
HIV treatment for children & young people

DNDi Launches New Drug Development Programme to Address Treatment Needs of Children with HIV/AIDS

Editor's pick
Drugs for Neglected Diseases Initiative
19 July 2011